Corpus Intelligence IC Memo — BRIGHTWELL BEHAVIORAL HEALTH 2026-04-26 18:04 UTC
IC Memo — BRIGHTWELL BEHAVIORAL HEALTH
Investment Committee Memorandum | IN | 22 beds | Grade D | EBITDA uplift $430K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BRIGHTWELL BEHAVIORAL HEALTH

CCN 154066 | CLARK, IN | 22 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BRIGHTWELL BEHAVIORAL HEALTH is a 22-bed community hospital in CLARK, IN with $5.7M in net patient revenue and a -7.9% operating margin. The hospital serves a payer mix of 86.3% Medicare, 0.0% Medicaid, and 13.7% commercial.

Thesis: Turnaround. Our ML models identify $430K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.9% to -0.3% (+756bps).

Net Revenue HCRIS$5.7M
Current EBITDA COMPUTED$-446K
Operating Margin COMPUTED-7.9%
Occupancy HCRIS79.8%
Revenue / Bed COMPUTED$258K
Net-to-Gross HCRIS55.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
76
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of -7.9% places it below the state median. Among 76 size-comparable peers (11-44 beds), the median margin is -4.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (11-44), prioritizing same-state peers. 76 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BRIGHTWELL BEHAVIORAL HEALTH (Target)IN22$5.7M-7.9%
INDIANA ORTHOPAEDIC HOSPITAL LIN38$196.8M31.2%
ORTHOPAEDIC HOSPT.AT PARKVIEWIN37$175.7M36.8%
LUTHERAN MUSCULOSKELETAL CENTEIN39$168.9M25.0%
MARGARET MARY COMMUNITY HOSPITIN25$124.5M-3.6%
KINGS DAUGHTERS HOSPITALIN43$123.4M-13.8%
MEMORIAL HOSPITAL LOGANSPORTIN37$103.6M-17.4%
CAMERON MEMORIAL COMMUNITY HOSIN25$95.1M7.4%
THE OTIS R. BOWEN CENTERIN20$92.4M-11.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $430K (756bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$119K+210bp18mo
Denial Rate Reduction12.0%6.5%$118K+207bp12mo
Cost to Collect4.5%2.5%$114K+200bp12mo
A/R Days Reduction5200.0%3800.0%$69K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+17bp6mo

5. EBITDA Bridge

Net Collection Rate
$119K
Denial Rate Reduction
$118K
Cost to Collect
$114K
A/R Days Reduction
$69K
Clean Claim Rate
$10K
Total EBITDA Uplift$430K
Current EBITDA$-446K
+ RCM Uplift+$430K
Pro Forma EBITDA$-17K
Current Margin-7.9%
Pro Forma Margin-0.3%
WC Released (1x)$218K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-687K$1.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-687K$1.3M0.00x-100.0%
Bull Case9.0x11.0x$-618K$2.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-618K$2.5M0.00x-100.0%
Bear Case11.0x10.0x$-755K$-573K0.00x-100.0%
Bear (11x exit)11.0x11.0x$-755K$-876K0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 86.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 76 hospitals with 11-44 beds
  • Same-state prioritization (n=77)
  • Comp margins: P25=-17.4% / P50=-4.8% / P75=6.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.